Finance

Lists
4019:TADAWUL
Specialized Medical Company SCJSC
SAR 14,20
+1,36%
(+0,19) 1D
13 Okt., 15:17:00 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4019...
Open
SAR 14,01
High
SAR 14,31
Low
SAR 13,99
Mkt. cap
3,55 mjd
Avg. vol.
258,60 k
Volume
228,77 k
Dividend
2,25%
Quarterly dividend
SAR 0,08
Ex-dividend date
18 Mei 2026
P/E ratio
12,77
52-wk high
SAR 21,49
52-wk low
SAR 13,99
EPS
SAR 1,11
Shares outstanding
246,47 m
No. of employees
3 k
Open
SAR 14,01
High
SAR 14,31
Low
SAR 13,99
Mkt. cap
3,55 mjd
Avg. vol.
258,60 k
Volume
228,77 k
Dividend
2,25%
Quarterly dividend
SAR 0,08
Ex-dividend date
18 Mei 2026
P/E ratio
12,77
52-wk high
SAR 21,49
52-wk low
SAR 13,99
EPS
SAR 1,11
Shares outstanding
246,47 m
No. of employees
3 k
News stories
From web sources and news partners
About Specialized Medical Company SCJSC
CEO-
Employees3,35 k
Founded1994
Headquarters-
SectorHealth care provider
Websitesmc.com.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
382,69 m
406,91 m
380,67 m
401,33 m
Cost of goods sold
280,94 m
323,31 m
289,71 m
301,20 m
Cost of revenue
280,94 m
323,31 m
289,71 m
301,20 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,85 m
11,77 m
49,88 m
44,59 m
Operating expense
27,85 m
11,77 m
49,88 m
44,59 m
Total operating expenses
308,79 m
335,08 m
339,59 m
345,79 m
Operating income
73,90 m
71,83 m
41,08 m
55,53 m
Other non operating income
6,98 m
7,21 m
2,98 m
2,82 m
EBT including unusual items
68,49 m
134,75 m
33,70 m
46,66 m
EBT excluding unusual items
68,49 m
74,12 m
33,70 m
46,66 m
Income tax expense
2,25 m
766,56 k
1,15 m
1,48 m
Effective tax rate
3,28%
0,57%
3,42%
3,17%
Other operating expenses
-
-
-
-
Net income
66,25 m
133,98 m
32,55 m
45,18 m
Net profit margin
17,31%
32,93%
8,55%
11,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-12,39 m
-4,92 m
-10,36 m
-11,70 m
Net interest expenses
-12,39 m
-4,92 m
-10,36 m
-11,70 m
Depreciation and amortization charges
-
-
-
-
EBITDA
90,07 m
87,47 m
57,71 m
71,89 m
Gain or loss from assets sale
170,94 k
-60,66 m
-
-
AI content may include mistakes. Learn more
Google-programme